Literature DB >> 19751968

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment.

Valeria Mondelli1, Paola Dazzan, Nilay Hepgul, Marta Di Forti, Monica Aas, Alessandro D'Albenzio, Marco Di Nicola, Helen Fisher, Rowena Handley, Tiago Reis Marques, Craig Morgan, Serena Navari, Heather Taylor, Andrew Papadopoulos, Katherine J Aitchison, Robin M Murray, Carmine M Pariante.   

Abstract

First-episode psychosis (FEP) patients show hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, but the mechanisms leading to this are still unclear. The aim of this study was to investigate the role of stress and antipsychotic treatment on diurnal cortisol levels, and on cortisol awakening response, in FEP. Recent stressful events, perceived stress and childhood trauma were collected in 50 FEP patients and 36 healthy controls using structured instruments. Salivary cortisol was obtained at awakening, at 15, 30, and 60min after awakening, and at 12 and 8pm. Patients experienced more recent stressful events, perceived stress and childhood trauma than controls (p<0.001). Patients had a trend for higher diurnal cortisol levels (p=0.055), with those with less than two weeks of antipsychotics showing significantly higher cortisol levels than both patients with more than two weeks of antipsychotics (p=0.005) and controls (p=0.002). Moreover, patients showed a blunted cortisol awakening response compared with controls, irrespectively of antipsychotic treatment (p=0.049). These abnormalities in patients were not driven by the excess of stressors: diurnal cortisol levels were negatively correlated with the number of recent stressful events (r=-0.36, p=0.014), and cortisol awakening response was positively correlated with a history of sexual childhood abuse (r=0.33, p=0.033). No significant correlations were found between perceived stress or severity of symptoms and cortisol levels, either diurnal or in the awakening response. Our study shows that antipsychotics normalize diurnal cortisol hyper-secretion but not the blunted cortisol awakening response in FEP; factors other than the excess of psychosocial stress explain HPA axis abnormalities in FEP. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751968      PMCID: PMC3513410          DOI: 10.1016/j.schres.2009.08.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  72 in total

1.  A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system.

Authors:  P McGuffin; A Farmer; I Harvey
Journal:  Arch Gen Psychiatry       Date:  1991-08

2.  The dexamethasone suppression test in schizophrenia.

Authors:  K Ismail; R M Murray; M J Wheeler; V O'Keane
Journal:  Psychol Med       Date:  1998-03       Impact factor: 7.723

3.  The List of Threatening Experiences: the reliability and validity of a brief life events questionnaire.

Authors:  T S Brugha; D Cragg
Journal:  Acta Psychiatr Scand       Date:  1990-07       Impact factor: 6.392

4.  Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.

Authors:  R Tandon; C Mazzara; J DeQuardo; K A Craig; J H Meador-Woodruff; R Goldman; J F Greden
Journal:  Biol Psychiatry       Date:  1991-05-15       Impact factor: 13.382

5.  Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.

Authors:  Xiang Yang Zhang; Dong Feng Zhou; Lian Yuan Cao; Gui Ying Wu; Yu Cun Shen
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

Review 6.  What causes the onset of psychosis?

Authors:  Matthew R Broome; James B Woolley; Paul Tabraham; Louise C Johns; Elvira Bramon; Graham K Murray; Carmine Pariante; Philip K McGuire; Robin M Murray
Journal:  Schizophr Res       Date:  2005-11-01       Impact factor: 4.939

7.  Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.

Authors:  C H Lammers; D Garcia-Borreguero; J Schmider; U Gotthardt; M Dettling; F Holsboer; I J Heuser
Journal:  Biol Psychiatry       Date:  1995-12-15       Impact factor: 13.382

Review 8.  Schizophrenia: a neural diathesis-stress model.

Authors:  E F Walker; D Diforio
Journal:  Psychol Rev       Date:  1997-10       Impact factor: 8.934

9.  Blunted cortisol response to a psychosocial stressor in schizophrenia.

Authors:  L M Jansen; C C Gispen-de Wied; P J Gademan; R C De Jonge; J A van der Linden; R S Kahn
Journal:  Schizophr Res       Date:  1998-09-07       Impact factor: 4.939

10.  Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study.

Authors:  P Bebbington; S Wilkins; P Jones; A Foerster; R Murray; B Toone; S Lewis
Journal:  Br J Psychiatry       Date:  1993-01       Impact factor: 9.319

View more
  76 in total

1.  Migration, ethnicity, and psychosis: toward a sociodevelopmental model.

Authors:  Craig Morgan; Monica Charalambides; Gerard Hutchinson; Robin M Murray
Journal:  Schizophr Bull       Date:  2010-05-30       Impact factor: 9.306

2.  Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis.

Authors:  M Aas; P Dazzan; V Mondelli; T Toulopoulou; A Reichenberg; M Di Forti; H L Fisher; R Handley; N Hepgul; T Marques; A Miorelli; H Taylor; M Russo; B Wiffen; A Papadopoulos; K J Aitchison; C Morgan; R M Murray; C M Pariante
Journal:  Psychol Med       Date:  2010-06-09       Impact factor: 7.723

3.  Nonhuman primate models of hippocampal development and dysfunction.

Authors:  Jocelyne Bachevalier
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

4.  The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis.

Authors:  Danielle M Moskow; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Tyrone D Cannon; Scott W Woods; Elaine F Walker
Journal:  Schizophr Res       Date:  2016-02-20       Impact factor: 4.939

Review 5.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

6.  From stress to psychosis: whom, how, when and why?

Authors:  V Mondelli
Journal:  Epidemiol Psychiatr Sci       Date:  2014-06-06       Impact factor: 6.892

7.  Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.

Authors:  Marco Armando; Corrado Sandini; Maelle Chambaz; Marie Schaer; Maude Schneider; Stephan Eliez
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

8.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

9.  Dual Cognitive and Biological Correlates of Anxiety in Autism Spectrum Disorders.

Authors:  Matthew J Hollocks; Andrew Pickles; Patricia Howlin; Emily Simonoff
Journal:  J Autism Dev Disord       Date:  2016-10

10.  Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.

Authors:  Valeria Mondelli; Carmine M Pariante; Serena Navari; Monica Aas; Alessandro D'Albenzio; Marta Di Forti; Rowena Handley; Nilay Hepgul; Tiago Reis Marques; Heather Taylor; Andrew S Papadopoulos; Katherine J Aitchison; Robin M Murray; Paola Dazzan
Journal:  Schizophr Res       Date:  2010-01-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.